These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10907591)
21. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Schachter LM; Salome CM; Peat JK; Woolcock AJ Thorax; 2001 Jan; 56(1):4-8. PubMed ID: 11120896 [TBL] [Abstract][Full Text] [Related]
22. Duration of asthma and lung function in life-long nonsmoking adults. Olaguibel Rivera JM; Alvarez-Puebla MJ; Puy Uribe San Martín M; Tallens Armand ML J Investig Allergol Clin Immunol; 2007; 17(4):236-41. PubMed ID: 17694695 [TBL] [Abstract][Full Text] [Related]
23. The relationship between airway hyper-responsiveness, markers of inflammation and lung function depends on the duration of the asthmatic disease. Grönke L; Kanniess F; Holz O; Jörres RA; Magnussen H Clin Exp Allergy; 2002 Jan; 32(1):57-63. PubMed ID: 12002738 [TBL] [Abstract][Full Text] [Related]
24. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Hansen EF; Phanareth K; Laursen LC; Kok-Jensen A; Dirksen A Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1267-71. PubMed ID: 10194175 [TBL] [Abstract][Full Text] [Related]
25. Observational study of the natural history of eosinophilic bronchitis. Berry MA; Hargadon B; McKenna S; Shaw D; Green RH; Brightling CE; Wardlaw AJ; Pavord ID Clin Exp Allergy; 2005 May; 35(5):598-601. PubMed ID: 15898981 [TBL] [Abstract][Full Text] [Related]
26. Prognostic factors for the outcome of childhood asthma in adolescence. Roorda RJ Thorax; 1996 Jan; 51 Suppl 1(Suppl 1):S7-12. PubMed ID: 8658386 [TBL] [Abstract][Full Text] [Related]
27. The importance of airway remodelling in the natural course of asthma. Janson C Clin Respir J; 2010 May; 4 Suppl 1():28-34. PubMed ID: 20500607 [TBL] [Abstract][Full Text] [Related]
28. Airway hyperresponsiveness and development of lung function in adolescence and adulthood. Harmsen L; Ulrik CS; Porsbjerg C; Thomsen SF; Holst C; Backer V Respir Med; 2014 May; 108(5):752-7. PubMed ID: 24512967 [TBL] [Abstract][Full Text] [Related]
29. Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype. Konstantellou E; Papaioannou AI; Loukides S; Patentalakis G; Papaporfyriou A; Hillas G; Papiris S; Koulouris N; Bakakos P; Kostikas K Respir Med; 2015 Nov; 109(11):1404-9. PubMed ID: 26412805 [TBL] [Abstract][Full Text] [Related]
30. Alternative functional criteria to assess airflow-limitation reversibility in asthma. Tavares e Castro A; Matos P; Tavares B; Matos MJ; Segorbe-Luís A Rev Port Pneumol (2006); 2015; 21(2):69-75. PubMed ID: 25926369 [TBL] [Abstract][Full Text] [Related]
31. Perception of bronchodilation in subjects with asthma and smokers with airflow limitation. Massasso DH; Salome CM; King GG; Seale JP; Woolcock AJ Respirology; 1999 Jun; 4(2):117-24. PubMed ID: 10382229 [TBL] [Abstract][Full Text] [Related]
32. Histopathology of severe childhood asthma: a case series. Jenkins HA; Cool C; Szefler SJ; Covar R; Brugman S; Gelfand EW; Spahn JD Chest; 2003 Jul; 124(1):32-41. PubMed ID: 12853499 [TBL] [Abstract][Full Text] [Related]
33. Asthma remission: does it exist? van den Toorn LM; Overbeek SE; Prins JB; Hoogsteden HC; de Jongste JC Curr Opin Pulm Med; 2003 Jan; 9(1):15-20. PubMed ID: 12476079 [TBL] [Abstract][Full Text] [Related]
34. Further Studies of Unsuspected Emphysema in Nonsmoking Patients With Asthma With Persistent Expiratory Airflow Obstruction. Gelb AF; Yamamoto A; Verbeken EK; Schein MJ; Moridzadeh R; Tran D; Fraser C; Barbers R; Elatre W; Koss MN; Glassy EF; Nadel JA Chest; 2018 Mar; 153(3):618-629. PubMed ID: 29197547 [TBL] [Abstract][Full Text] [Related]
35. Relationship between airway pathophysiology and airway inflammation in older asthmatics. Porsbjerg CM; Gibson PG; Pretto JJ; Salome CM; Brown NJ; Berend N; King GG Respirology; 2013 Oct; 18(7):1128-34. PubMed ID: 23734667 [TBL] [Abstract][Full Text] [Related]
37. Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Lee JH; Haselkorn T; Borish L; Rasouliyan L; Chipps BE; Wenzel SE Chest; 2007 Dec; 132(6):1882-9. PubMed ID: 18079222 [TBL] [Abstract][Full Text] [Related]
38. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Saglani S; Malmström K; Pelkonen AS; Malmberg LP; Lindahl H; Kajosaari M; Turpeinen M; Rogers AV; Payne DN; Bush A; Haahtela T; Mäkelä MJ; Jeffery PK Am J Respir Crit Care Med; 2005 Apr; 171(7):722-7. PubMed ID: 15657459 [TBL] [Abstract][Full Text] [Related]